Endometriosisassociated breast dysplasia features of diagnosis and treatment

Summary. The urgency of the problems of combined diseases of the reproductive system of women is due primarily the growth of this pathology worldwide. In recent years, there has been a tendency to increase the incidence of benign breast dysplasia , diagnosed in every 4 women [1]. All over the world, women in which diagnosed breast dysplasia , have an increased risk of breast cancer. Breast cancer ranks first among malignant diseases in women. The problem of benign combined pathology of the uterus and breast (GZ) is one of the most relevant in modern gynecology, due to the fact that hyperplastic processes of the uterus (GPM) and benign breast diseases (DZGZ) occupy one of the leading places in the structure of gynecological morbidity [2]. The aim of the study – to analyze the data of the modern literature to increase the effectiveness of treatment of endometriosis -associated dysplasia of the mammary glands by studying the clinic and features of early diagnosis. Materials and methods. With the help of Internet search databases, a review and analysis of materials on endometriosis -associated breast dysplasia was performed. The data of pathogenesis, diagnosis and treatment of combined pathology of the mammary glands are analyzed. Results. The literature convincingly suggests that the processes occurring in the GH are closely related to the function of the reproductive system. It is known that GZ is not only a target for steroids, but also for pituitary hormones, thyroid hormones, adrenal glands , etc. This significantly increases the likelihood of developing pathology of the gastrointestinal tract in disorders of the reproductive system and in patients with hormone-dependent gynecological diseases [2]. IN women younger 35 years with purpose decrease radial load on the woman's body at palpatory detection of a volume new growth in a mammary gland for diagnosis it is expedient to use instead of a mammography - ultrasonography of mammary glands . The "gold standard" of breast examination is bilateral mammography, which is due to: radioresistance of mature breast tissue, low radiation dose of modern devices, high efficiency of diagnosis of asymptomatic malignant tumors: 85–90 %. Evidence-based data confirm the effectiveness of herbal and homeopathic remedies. In the treatment of mastopathy and other hypertrophic dysplasia in women; depending on the clinical form of the disease, herbal medicine provides a significant improvement or recovery of 40–87 % of patients [3]. Conclusions. Summarizing all the above, we can safely say that understanding the pathogenesis, algorithms for diagnosis and treatment of edometriosis -associated breast dysplasia will help obstetricians provide qualified care to patients, improve the quality of life of women and prescribe the most effective treatment for this pathology

combined diseases, endometriosis, dyshor­monal diseases of the mammary glands, hyperplastic processes, hyperestrogenism

https://doi.org/10.11603/bmbr.2706-6290.2022.2.13048

[1] Kruk OY. [The problem of combined diseases of the reproductive system of women]. Visn Vinnyts nats univer. 2019;4: 733-39. Ukrainian.

[2] Sheligin  MS. [Combined  benign  pathology  of  the uterus and breasts in women of reproductive age: diagnosis and treatment tactics]. Zdorov zhenshch. 2014;9(95): 158-60. Ukrainian.

[3] Radzinsky  VE,  Ordyants  IM,  Maslennikova  MN,Pavlova  EA. [Breasts  and  gynecological  diseases: from  common  pathogenetic  views  to  practical  solution]. Reprodukt endokrinol. 2014;2(16): 72-80.

[4] Likhachev VK. Gynecology: a guide for doctors. [Гінекологія : керівництво для лікарів] Vinnytsia: Nova Knyha;2018. Ukrainian.

[5] Voloshina NN, Pashchenko SN, Shchurov NF. [Non-hormonal therapy of proliferative processes of the breast and endometrium]. Zdorov zhenshch. 2013;1: 94-8. Russian.

[6] Golovko  TS.[Mastodynia  in  the  practice  of oncomammology].Z turbotoiu pro zhinku. 2015;3 (60): 6-9.Ukrainian.

[7] Zhuk SI.[Benign dysplasia of the mammary glands: a review of recent studies].Zhin likar. 2016;6 (67): 34-8.Ukrainian.

[8] Likhachev  VK.  Hormonal  diagnostics  in  obstetrics and gynecology. [Гормональна діагностика в акушерстві та гінекології] Poltava: Dyvosvit; 2015. Ukrainian.

[9] Likhachev  VK,  Dobrovolskaya  LM,  Semenyuk  LM, Yaremchuk  LV.  Obstetrics  and  gynecology:  Workshop. [Акушерство та гінекологія: практикум] Poltava: Dyvosvit;2014. Ukrainian.

[10] Shurpiak S.О.  Substantiation  of  pathogenetic disease of patients with fibrocystic disease. Zdorovia zhin. 2015;103(7):147-50. Ukrainian.

[11] Carauleanu A, Socolov R, Rugina V. Comparisons between  the  non-proliferative  and  proliferative  therapy in  fibrocystic  mastosis.  Rev  Med  Chir  Soc  Med  NatIasi. 2016;120(2): 321-7.

[12] Charlson M, Wells MT, Ullman R, King F, Shmukler C. The Charlson comorbidity index can be used prospectively to identify patients who will incur high future costs. PLoS ONE. 2014;9(12):  e112479  DOI:10.1371/journal.pone. 0112479

[13] Claus  EB,  Stowe  M, Carter  D.  Family  history  of breast and ovarian cancer and risk of breast carcinoma in situ. Breast Cancer Res. Treat. 2013;78(1):7-15.

[14] Czernobilsky  B.  Endometriosis.  In  H.  Fox  (Ed.). Obstetrical  and  Gynecological  Pathology.  New  York: Churchill Living stone; 2015.

[15] Villiers  de  TJ,  Pines  A,  Panay  N,  Gambacciani M, Archer DF, Baber RJ, Sturdee DW. Updated 2013 In-ternational  Menopause  Society  recommendations  on menopausal  hormone  therapy  and  preventive  strate-gies  for  midlife  health.  Climacteric.  2013;16(3): 316-37. DOI: 10.3109/13697137.2013.795683.

[16] Gold  EB,  Crawford  SL,  Avis  NE,  Crandall  CJ, Matthews  KA,  Waetjen  LE,  Harlow  SD.  Factors  related to  age  at  natural  menopause:  longitudinal  analyses  from SWAN. Am JEpidemiol. 2013;178.

[17] Gorban NYe, Zadorozhna TD, Vovk IB, Zhulkevych IV. Morphological features of uterine polyps in females of reproductive age. Visn nauk doslidzh. 2019;2: 47-52.